11:13 AM EDT, 03/20/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.47% to 1,438.05 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet ad company Criteo ( CRTO ) and biotech firm Evaxion Biotech ( EVAX ) , which rose 2.7% and 2.4%, respectively. They were followed by telecommunications company Ericsson (ERIC) and pharmaceutical company Novo Nordisk ( NVO ) , which were up 0.4% and 0.2%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and financial services company Banco Santander (SAN), which fell 4.2% and 3.8%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) and accommodations booking site trivago (TRVG), which dropped 3.2% and 3%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and TC Biopharm ( TCBP ) , which advanced 5.9% and 4.9%, respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Trinity Biotech ( TRIB ) , which increased 3% and 2.7%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Biodexa Pharmaceuticals ( BDRX ) , which tumbled 23% and 12%, respectively. They were followed by education company Pearson (PSO) and financial services company HSBC ( HSBC ) , which were down 5% and 2.5%, respectively.